Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized Adenosine Monophosphate
Baseline variables included in the multiple linear regression analysis for PC20 AMP were age, smoking status, blood eosinophils, FEV1, residual volume (RV), and ventilation heterogeneity of the conductive lung zone. The present work shows that bronchial provocation with dry powder adenosine is a sui...
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 197; no. 3; pp. 391 - 394 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Thoracic Society
01.02.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 1073-449X 1535-4970 1535-4970 |
DOI | 10.1164/rccm.201704-0715LE |
Cover
Summary: | Baseline variables included in the multiple linear regression analysis for PC20 AMP were age, smoking status, blood eosinophils, FEV1, residual volume (RV), and ventilation heterogeneity of the conductive lung zone. The present work shows that bronchial provocation with dry powder adenosine is a suitable method for measuring AHR in asthmatic subjects. [...]the new testing method allowed us to administer higher doses, resulting in fewer false-negative test results, and the degree of AHR to dry powder adenosine correlated well with the degree of AHR to nebulized AMP. There was, however, no apparent relationship between measures of airway obstruction at baseline and PD20 adenosine (e.g., only two out of nine had an FEV1/FVC ratio ,70%) or with their smoking status (four were current and five were former smokers). [...]we expect that increasing the top dose, which was arbitrarily chosen to be 80 mg in this study, could further reduce the number of false negatives and thus increase the test's sensitivity even more. [...]we have shown that bronchial provocation with dry powder adenosine is a suitable alternative to provocation with nebulized AMP, considering the good agreement between the tests and comparable baseline predictors. [...]dry powder adenosine appears to offer an improvement over nebulized AMP because of its higher sensitivity for less hyperresponsive subjects with asthma. n Author disclosures are available with the text of this letter at www.atsjournals.org. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Correspondence-2 content type line 14 ObjectType-Letter to the Editor-1 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
ISSN: | 1073-449X 1535-4970 1535-4970 |
DOI: | 10.1164/rccm.201704-0715LE |